154 related articles for article (PubMed ID: 19696165)
21. Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers.
Veliça P; Davies NJ; Rocha PP; Schrewe H; Ride JP; Bunce CM
Mol Cancer; 2009 Dec; 8():121. PubMed ID: 20003443
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts.
Roberson AE; Hyatt K; Kenkel C; Hanson K; Myers DA
Reprod Sci; 2012 Mar; 19(3):271-81. PubMed ID: 22064385
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
24. The roles of aldo-keto reductases in steroid hormone action.
Bauman DR; Steckelbroeck S; Penning TM
Drug News Perspect; 2004 Nov; 17(9):563-78. PubMed ID: 15645014
[TBL] [Abstract][Full Text] [Related]
25. Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily.
Hara A; Endo S; Matsunaga T; Soda M; Yashiro K; El-Kabbani O
J Biochem; 2017 Nov; 162(5):371-379. PubMed ID: 28992312
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid-induced androgen inactivation by aldo-keto reductase 1C2 promotes adipogenesis in human preadipocytes.
Veilleux A; Côté JA; Blouin K; Nadeau M; Pelletier M; Marceau P; Laberge PY; Luu-The V; Tchernof A
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E941-9. PubMed ID: 22275760
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human colon cancer cells resistant to methotrexate: role in the cell cycle and apoptosis.
Selga E; Noé V; Ciudad CJ
Biochem Pharmacol; 2008 Jan; 75(2):414-26. PubMed ID: 17945194
[TBL] [Abstract][Full Text] [Related]
28. Androgen metabolism in adipose tissue: recent advances.
Blouin K; Veilleux A; Luu-The V; Tchernof A
Mol Cell Endocrinol; 2009 Mar; 301(1-2):97-103. PubMed ID: 19022338
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
[TBL] [Abstract][Full Text] [Related]
30. Localization and altered expression of AKR1C family members in human ovarian tissues.
Ji Q; Aoyama C; Chen PK; Stolz A; Liu P
Mol Cell Probes; 2005 Aug; 19(4):261-6. PubMed ID: 15979276
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the Potential of Bile Acid Methyl Esters as Inhibitors of Aldo-keto Reductase 1C2: Insight from Molecular Docking, Virtual Screening, Experimental Assays and Molecular Dynamics.
Marinović MA; Petri ET; Grbović LM; Vasiljević BR; Jovanović-Šanta SS; Bekić SS; Ćelić AS
Mol Inform; 2022 Oct; 41(10):e2100256. PubMed ID: 35393780
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the aldo-keto reductase 1C gene cluster on pig chromosome 10: possible associations with reproductive traits.
Nonneman DJ; Wise TH; Ford JJ; Kuehn LA; Rohrer GA
BMC Vet Res; 2006 Sep; 2():28. PubMed ID: 16970816
[TBL] [Abstract][Full Text] [Related]
33. Ruthenium complexes as inhibitors of the aldo-keto reductases AKR1C1-1C3.
Traven K; Sinreih M; Stojan J; Seršen S; Kljun J; Bezenšek J; Stanovnik B; Turel I; Rižner TL
Chem Biol Interact; 2015 Jun; 234():349-59. PubMed ID: 25446855
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.
Alshogran OY
Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1063-1073. PubMed ID: 28871815
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of the synthetic progestogen norethynodrel by human ketosteroid reductases of the aldo-keto reductase superfamily.
Jin Y; Duan L; Chen M; Penning TM; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):139-44. PubMed ID: 22210085
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives.
Sinreih M; Jójárt R; Kele Z; Büdefeld T; Paragi G; Mernyák E; Rižner TL
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1500-1508. PubMed ID: 34227437
[TBL] [Abstract][Full Text] [Related]
37. Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man.
Wsol V; Szotakova B; Martin HJ; Maser E
Toxicology; 2007 Sep; 238(2-3):111-8. PubMed ID: 17618725
[TBL] [Abstract][Full Text] [Related]
38. Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone.
Murray JR; Mesaros CA; Arlt VM; Seidel A; Blair IA; Penning TM
Chem Res Toxicol; 2018 Nov; 31(11):1277-1288. PubMed ID: 30406992
[TBL] [Abstract][Full Text] [Related]
39. Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death.
Phoo NLL; Dejkriengkraikul P; Khaw-On P; Yodkeeree S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830394
[TBL] [Abstract][Full Text] [Related]
40. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
